The trend of embryo gene screening is rising in Silicon Valley, with tech elites pursuing high-priced intelligence tests.

Silicon Valley tech executives are enthusiastic about embryo genetic screening, with startups offering intelligence predictions services priced at up to $50,000. Companies like Herasight and Nucleus Genomics have seen a significant increase in business.